| Price Range 12mo avg: | $2M – $2.5M |
|---|---|
| $/sf 12mo avg: | $318.75 |
| CAP Rate 12mo avg: | 7.29% |
| NOI average: | $173,700 |
| Lease Terms: | 15yrs NNN |
| Building Size avg: | 7,500 SF |
| Lot Size avg: | 2.5+/- acres |
Fresenius is a global health care group with products and services for dialysis, the hospital and the medical care of patients at home.
The Fresenius Group consists of the following four business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed.
Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and the New York Stock Exchange (FMS)
Fresenius Medical Care is the world’s largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 2.7 million individuals worldwide. Through its network of 3,361 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatments for 286,312 patients around the globe. Fresenius Medical Care is also the world’s leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products.
| S&P Credit Rating: | BBB- |
|---|---|
| Moody’s Credit Rating: | Ba1 |
| Annual Revenue 2014: | $15.8B |
| Annual Revenue 2013: | $14.6B |
| Revenue Growth: | ↑ 8% from 2013 |
| Net Income | $1.05B |
| Units (Dec. 2014) | 3,361 |
| Average Units Volume: | $4.7M |
Yahoo! Finance: FMS News Latest Financial News for FMS
-
Hedge Funds Are Souring On Fresenius Medical Care AG & Co. KGaA (FMS)
on July 6, 2020 at 1:31 pm
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […]
-
RBC Capital Sticks to Their Hold Rating for Fresenius Medical Care Corp.
on May 18, 2020 at 11:43 am
RBC Capital analyst Frank Morgan maintained a Hold rating on Fresenius Medical Care (NYSE:FMS) Corp. on Thursday, setting a price target of $42, which is approximately 6.90% above the present share price of $39.29. […]
-
Is Fresenius Medical Care AG & Co. KGaA (ETR:FME) A Smart Pick For Income Investors?
on May 16, 2020 at 7:40 am
Is Fresenius Medical Care AG & Co. KGaA (ETR:FME) a good dividend stock? How can we tell? Dividend paying companies... […]
-
Nursing the World to Health: Celebrating Fresenius Kidney Care Nurses’ Contribution in Asia Pacific on International Nurses Day
on May 12, 2020 at 3:27 am
Today, on International Nurses Day, Fresenius Medical Care, the world’s leading provider of dialysis products and services, is celebrating the extraordinary contribution that its nurses make to the organization and wider community – every day, and particularly in the face of our current global health challenge. […]
-
Fresenius Medical (FMS) Q1 Earnings Miss Estimates, Fall Y/Y
on May 11, 2020 at 2:26 pm
Fresenius Medical's (FMS) first-quarter earnings benefit from strong segmental performance. […]
NYSE: FMS
